NTM drug discovery: status, gaps and the way forward.

about

Novel Screen to Assess Bactericidal Activity of Compounds Against Non-replicating The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Drug Resistance Mycobacterial Cell Wall Synthesis Inhibitors Cause Lethal ATP Burst

P2860

Q58575893-C68C256B-6B4D-44E3-8C78-2584489E6428 Q58746601-C9E35FCB-0E3C-49C9-B029-1A0FF447DAC3 Q58777351-E176EDA0-D055-4EE5-AF3C-11A88BA1043F

P2860

NTM drug discovery: status, gaps and the way forward.

Item

http://www.wikidata.org/entity/Q52596288

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

NTM drug discovery: status, gaps and the way forward.

@en

NTM drug discovery: status, gaps and the way forward.

@nl

type

Item

label

NTM drug discovery: status, gaps and the way forward.

@en

NTM drug discovery: status, gaps and the way forward.

@nl

prefLabel

NTM drug discovery: status, gaps and the way forward.

@en

NTM drug discovery: status, gaps and the way forward.

@nl

P1476

NTM drug discovery: status, gaps and the way forward

@en

P2093

Dinah B Aziz

http://www.w3.org/2001/XMLSchema#string

Mu-Lu Wu

http://www.w3.org/2001/XMLSchema#string

Véronique Dartois

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

Update on pulmonary disease due to non-tuberculous mycobacteria

Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses

A new dehydratase conferring innate resistance to thiacetazone and intra-amoebal survival of Mycobacterium smegmatis

Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review

Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex

Mefloquine is active in vitro and in vivo against Mycobacterium avium complex

First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol

Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria

Isolation of two subpopulations of Mycobacterium avium within human macrophages

P304

1502-1519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUDIS.2018.04.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Dick

P577

2018-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29635026

http://www.w3.org/2001/XMLSchema#string

P932

6078814

http://www.w3.org/2001/XMLSchema#string

NTM drug discovery: status, gaps and the way forward.

about

P2860

P2860

NTM drug discovery: status, gaps and the way forward.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932